Navigation Links
Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
Date:2/24/2009

PALO ALTO, Calif., Feb. 24 /PRNewswire/ -- Today, Genencor, a division of Danisco A/S, launched Accellerase(R) 1500, the next generation of its cellulosic ethanol enzyme product. Genencor introduced the product at the Renewable Fuels Association (RFA) 2009 National Ethanol Conference in San Antonio, TX.

Accellerase(R) 1500 is another significant step toward commercialization of biofuels and other biochemicals made from cellulosic feedstocks, such as agricultural residues and bioenergy crops. It also reinforces Genencor's position as a global leader in 2nd generation ethanol innovation.

"We're on course to fast-track commercialization of cellulosic ethanol," says Philippe Lavielle, Senior Vice President, Business Development, Genencor. "Accellerase was a breakthrough in the industry. Now, by launching this improved enzyme product, we reach another important technical milestone toward commercial-scale production of transportation fuel and other biochemicals from renewable, non-food feedstocks."

Accellerase(R) 1500 will lower one of the major cost hurdles to producing ethanol or biochemicals from cellulosic feedstocks, such as corn stover, sugarcane bagasse, wood chips, wheat straw, and switchgrass. In addition, Accellerase(R) 1500 has a significantly improved formulation and higher activity resulting in higher ethanol yields and robust operation in a wider variety of processes. The product is based on Genencor's patented gene expression technology and the division's 25-year history of biofuels research.

Accellerase(R) is critical to the hydrolysis step of converting biomass to ethanol or other biochemicals. In this step, plant material is broken down into sugars for fermentation to ethanol.

Genencor supplies Accellerase(R) as part of its dual-strategy to drive forward the cellulosic ethanol industry, which includes its dedicated enzyme business, and its joint venture DuPon
'/>"/>

SOURCE Genencor
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
2. Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol
3. Genencor Appoints New Executive Vice President - Technical Enzymes
4. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
5. EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention
6. Smith & Nephew Launches VISIONAIRE(TM) Patient Matched Technology for Total Knee Replacement
7. CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas
8. BioSpace.com Launches a New Season of Industry Career Fairs
9. Millipore Launches an Interactive Biological Pathway Tool Using GeneGos Manually Curated Pathway Maps
10. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
11. Cephalons New Product Launches Pace Record 2008 Sales

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...mary efficacy endpoint has been met for patients w...ncer, , QUEBEC CITY, Nov. 24 /PRNewswire-Firs...X: AEZ) (the "Company"), a global biopharmaceutica...y, today announced positive efficacy data from a P...onjugate, AEZS-108 (formerly AN-152), in patients ...
(Date:11/24/2009)...IN, November 24 Shire pl...y biopharmaceutical company, today,announced that ...gency for,velaglucerase alfa, the company,s enzyme...ent of Type 1 Gaucher disease. This is the third m...as been submitted, with previous,submissions in th...
(Date:11/24/2009)... CITY, Calif., Nov. 24 G...ed that Randy Scott, Genomic Health,s Executive Ch...ray Health Care Conference in New York City on Tue... access the live and subsequently archived webcast... section of Genomic Health,s website at http://in...
(Date:11/24/2009)... Program Connects Customers with Partners Vali...h DNA Genotek Products , ...ek , a leading provider of products for biological... today announced its new global partner program. T... Genotek,s partner community and is designed to he...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...Nell Merlino and Laurie Benson may be as different...re an enriching vision for women entrepreneurs, in... ,Their vision has dollar signs as far as the eye ...source of economic growth - women who want to take...he million-dollar level. , ,Merlino, the creative...
...at for the White Sox this year and as for the C...l next year." What we cannot "wait until next year...n for connectivity for all of Chicago. , ,There sh...lopment of a wireless infrastructure as there is o...ybe the media is so forlorn about backing mediocri...
...The dizzying pace of change sparked by the informa... workable solutions abound to almost every busines...siness? , ,Based on anecdotal evidence collected a...sults are mixed but getting better. The conference...ght together more than 300 corporate clients and r...
Other Biology Technology:Women entrepreneurs reach for $1M level 2Women entrepreneurs reach for $1M level 3Wait `till next year OK for baseball, not broadband 2Wait `till next year OK for baseball, not broadband 3Wait `till next year OK for baseball, not broadband 4Wait `till next year OK for baseball, not broadband 5Are businesses getting what they need from IT? 2Are businesses getting what they need from IT? 3
(Date:11/23/2009)...CINCINNATINew research presents strong evidence th... to both outdoor traffic-related pollution and ind... than one or the other exposure alone. , Envir...ncinnati (UC) College of Medicine have shown that ...lated particles and indoor endotoxin during early ...
(Date:11/23/2009)... A new study by the Wildlife Conservation Society...rge swamp in the Republic of Congopart of the "mot... last yearare becoming increasingly threatened by ...dy recommends protection of the swamp forests adja...eserve after recent surveys confirmed that high de...
(Date:11/23/2009)..., AMES, Iowa - The only swine vaccine available fo...e herd infected with the virus. The vaccination ma...e herd diagnosed with the pandemic flu., Iowa St...science, developed the vaccine this summer and has... in Iowa, Kansas and Illinois for several weeks.,...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2House Energy 26 Commerce Committee Accepts Independence at Home Pilot Program as Amendment During Health Bill Markup 53369 1House Energy 26 Commerce Committee Accepts Independence at Home Pilot Program as Amendment During Health Bill Markup 53369 2Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday August 4 2009 After Close of U S Based Financial Markets 13310 1Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday August 4 2009 After Close of U S Based Financial Markets 13310 2Breast CT Scanner Could Improve Cancer Screen Comfort 53364 1Breast CT Scanner Could Improve Cancer Screen Comfort 53364 2Breast CT Scanner Could Improve Cancer Screen Comfort 53364 3
... our body,s cells normally auto-destruct may play ...esearch published online in the journal Apoptosis... or programmed cell death. , Doctors know that ge...affects nearly everyone older than 60, as well as ...100 genes are known to play a role in congenital d...
...l and diseased tissues behave differently. But a m...day give medical science a new way to fight obesit...rders of the metabolism. , Until now, scientists ...level, since they lacked information about the met... liver, heart and brain. , But a new computation...
...e function of the strange, bony crests on the head...s. The structures contain incredibly long, convolu...heir skulls. , Scientists at the University of To...y now have used CT-scanning to look inside these m...sal cavities of four different lambeosaur species....
Other Biology News:Genes that control cell death fingered in age-related hearing loss 2Genes that control cell death fingered in age-related hearing loss 3Could Dr. House be replaced by a computer? 2Key to function of dinosaur crests found in brain structure 2
Chicken Anti-Human Quinolinate phosphoribosyltransferase Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Anti-J Chain Monoclonal Antibody, Unconjugated, Clone M19/9J from CHEMICON
Tissue Stat from Biomeda Corporation
Clarion Mounting Medium - 6X100 ml from Biomeda Corporation
Biology Products: